CAMBRIDGE, Mass.--(BUSINESS WIRE)--Semprus BioSciences, Corp., today announced the appointment of Douglas Weaver to the new position of Group Leader, Process Development, effective immediately. In this role, Doug will spearhead the company’s effort to complete the development of manufacturing processes and scale up of Semprus’ proprietary vascular access product platform. This line features the company’s long acting Semprus Sustain™ Performance, the first non-leaching single surface modification that simultaneously reduces bacterial growth and thrombus formation (blood clots) on medical devices with multi-month efficacy.
